{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:46:39Z","timestamp":1783032399217,"version":"3.54.6"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,31]]},"DOI":"10.1097\/qad.0b013e3281c6148d","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T08:10:48Z","timestamp":1178871048000},"page":"1147-1155","source":"Crossref","is-referenced-by-count":28,"title":["Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients"],"prefix":"10.1097","volume":"21","author":[{"given":"Mona R","family":"Loutfy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M","family":"Raboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Halpenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene","family":"Ellenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davia","family":"Ezekiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Beninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","first-page":"546","article-title":"Psychosocial impact of the lipodystrophy syndrome in HIV infection","volume":"10","author":"Collins","year":"2000","journal-title":"AIDS Reader"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/108729102760330254","article-title":"Lipodystrophy syndrome and self-assessment of well being and physical appearance in HIV-positive patients","volume":"16","author":"Oette","year":"2002","journal-title":"AIDS Patient Care STDS"},{"issue":"Suppl 4","key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/01.aids.0000191485.92285.c7","article-title":"Self-perception of body changes in persons living with HIV\/AIDS: prevalence and associated factors","volume":"19","author":"Santos","year":"2005","journal-title":"AIDS"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001432-200502000-00005","article-title":"Interventions for managing antiretroviral therapy-associated lipoatrophy","volume":"18","author":"Sutinen","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/343051","article-title":"Effects of recombinant human growth hormone on fat redistribution in patients with human immunodeficiency virus-associated wasting","volume":"35","author":"Tai","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1210\/jcem.86.8.7785","article-title":"The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation","volume":"86","author":"Lo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomized, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"R11-8-20210130","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New-Fill)\u00ae to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"R12-8-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med"},{"key":"R14-8-20210130","first-page":"L36","article-title":"Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy [Abstract]","volume":"9","author":"Mest","year":"2004","journal-title":"Antivir Ther"},{"key":"R15-8-20210130","first-page":"209","article-title":"Bio-Alcamid: a novelty for reconstructive and cosmetic surgery","volume":"107","author":"Pacini","year":"2002","journal-title":"It J Anat Embryol"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/14764170310021922","article-title":"Bio-Alcamid\u2122 in drug-induced lipodystrophy","volume":"5","author":"Protopapa","year":"2003","journal-title":"J Cosmet Laser Ther"},{"key":"R17-8-20210130","first-page":"804","article-title":"Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV-positive patients undergoing treatment with antiretroviral drugs","volume":"32","author":"Treacy","year":"2006","journal-title":"Dermatol Surg"},{"key":"R18-8-20210130","first-page":"979","article-title":"HIV-associated facial lipoatrophy","volume":"28","author":"James","year":"2002","journal-title":"Dermatol Surg"},{"key":"R19-8-20210130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1018451930750","article-title":"Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)","volume":"6","author":"Wu","year":"1997","journal-title":"Qual Life Res"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1207\/s15327752jpa7103_5","article-title":"Evaluating anxiety and depression in HIV-infected patients","volume":"71","author":"Savard","year":"1998","journal-title":"J Pers Assess"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10 years experience of the Dermatology Life Quality Index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J Invest Dermatol Symp Proc"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e3281c6148d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:28:38Z","timestamp":1620970118000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200705310-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,31]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3281c6148d","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5,31]]}}}